Market Cap

Eurofins-Cerep Market Capitalization:

€146.3 Million

EUR as of July 1, 2023

US$159.7 Million

business Eurofins-Cerep Company Profile

Eurofins-Cerep Main Stock Listing

show_chart Euronext: ALECR

Market Capitalization History of Eurofins-Cerep

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $417.05 B
Johnson & Johnson $412.24 B
Merck $275.82 B
Roche $241.08 B
AbbVie $239.18 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $428.70 B
Lilly $417.05 B
Johnson & Johnson $412.24 B
Novo Nordisk $329.83 B
Merck $275.82 B

Yearly evolution of Eurofins-Cerep market cap

Date Market Cap YoY Change
Jan. 1, 2023 €111.2 M 26.71%
Jan. 1, 2022 €87.8 M 32.82%
Jan. 1, 2021 €66.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

flash_on

Unlock the Power of Financial AI:

Try Disfold AI Free for 7 Days!

Eurofins-Cerep Categories

France languages Healthcare languages Drug Manufacturers—General
France Healthcare France Drug Manufacturers—General

Stocks & Indices

Eurofins-Cerep has the following listings and related stock indices.


Stock: Euronext: ALECR

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.